Vertex Pharmaceuticals (NASDAQ: VRTX) and Mirum Pharmaceuticals (NASDAQ: MIRM) are two biotech stocks that share the same ...
A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers ...
A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers ...
Vertex Pharmaceuticals' business will suffer if other drugmakers launch competing cystic fibrosis drugs. Despite this threat, ...
A computational study shows for the first time how different parts of the human airway experience levels of pressure and ...
In a bar, a poet meets the man behind the drug that saved his life — discovering how science, faith and chance created a ...
Dr Uta Hill joins the Clinical Excellence in Respiratory Care speaker line-up to discuss adult cystic fibrosis services and ...
Bacteriophages (phages) are viruses that kill bacteria. Phage therapy used as an experimental therapy in 51 cystic fibrosis patients with multi-drug resistant infections showed that most had a ...
This editorial by Lucas Grundmeier represents the views of the Register's editorial board. The new report “Miracle of Breath” from the Register’s Iowa columnist, Courtney Crowder, spans decades to ...
Office was a generous word for the room in which Dr. Mike Welsh did lots of his research. Large closet fits better. Welsh was mostly alone, hunched over specialized microscopic equipment on a ...
Modulator pills transformed cystic fibrosis care. But the fight for a cure is not over — so long as research remains funded.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results